TK-285
TK-285 is a potent TSLP inhibitor that suppresses the production of TSLP and inhibits the expression of interleukin-33 mRNA. TK-285 exhibits a selective binding preference for the BD1 domains of BRD2, BRD3, BRD4 and BRDT. TK-285 can be used in research related to atopic dermatitis.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- 分子式: C28H30N2O5
- 分子量:474.55
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
TK-285 (0.1-10 μM; 24 h) dose-dependently inhibits TSLP production in mouse keratinocyte KCMH-1 cells after 24 h treatment, achieving significant inhibition at concentrations as low as 0.3 μM[1].
TK-285 binds strongly to the BD1 domain of BRD4 with a Kd of 190 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
化学情報
-
分子量 474.55
-
分子式 C28H30N2O5
-
SMILES
CC(NCCC1=C(C(/C=C/C2=CC=CC=C2OCC3=CN=CC=C3)=O)C=C(OCC)C(OC)=C1)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)